Case report 68Ga-DOTATATE of optic nerve sheath meningioma

Case report 68Ga-DOTATATE of optic nerve sheath meningioma

We report a patient with an optic nerve sheath meningioma whose diagnosis and management were guided by using Gallium-68 DOTA-Tyr3-octreotatate (68Ga-DOTATATE).Positron Emission Tomography-Computed Tomography (PET-CT).

Bibliographic Details
Main Authors:	Adeleh Yarmohammadi, Peter J. Savino, Sonya J. Koo, Roland R. Lee
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	American Journal of Ophthalmology Case Reports
Subjects:	Meningioma Molecular imaging Somatostatin receptor PET-CT 68Ga-DOTATATE
Online Access:	http://www.sciencedirect.com/science/article/pii/S2451993621000396

Similar Items

The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report
by: Karine A. Al Feghali, et al.
Published: (2018-10-01)

Metastatic urinary bladder paraganglioma on Ga-68 DOTATATE PET/CT
by: Andrew Ko, BSA, et al.
Published: (2021-09-01)

68Ga-DOTATATE PET imaging in clinically non-functioning pituitary macroadenomas
by: Tessel M. Boertien, et al.
Published: (2020-02-01)

Is 68Ga-DOTATATE the answer in lung carcinoid? : Case report and review of literature
by: Amit Bhoil, et al.
Published: (2012-01-01)

68Ga DOTATATE Uptake in Hemangioma Simulating Metastasis on PET Imaging
by: Bart Vertenten, et al.
Published: (2019-06-01)

Pulmonary large cell neuroendocrine carcinoma (LCNEC) with confirmed liver metastases negative on 18F-FDG and 68Ga-DOTATATE PET
by: Gaia Ninatti, et al.
Published: (2020-12-01)

68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
by: Pezhman Shahrokhi, et al.
Published: (2020-01-01)

Prevalence of hitherto unknown brain meningioma detected on 68Ga-DOTATATE positron-emission tomography/computed tomography in patients with metastatic neuroendocrine tumor and exploring potential of177Lu-DOTATATE peptide receptor radionuclide therapy as single-shot treatment approach targeting both tumors
by: Rahul V Parghane, et al.
Published: (2019-01-01)

Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE post-therapy whole body scintigraphy
by: Ashwin Parihar, et al.
Published: (2020-07-01)

Incidental prostate-specific membrane antigen-avid meningioma detected on 68Ga–prostate-specific membrane antigen PET/CT
by: James Yuheng Jiang, MD, MMed (ClinEpi), et al.
Published: (2021-11-01)

Comparison of 18F‐FDG PET/CT and 68Ga‐DOTATATE PET/CT in the Targeted Imaging of Culprit Tumors Causing Osteomalacia
by: Hao‐nan Yu, et al.
Published: (2021-05-01)

Efficacy of Galium-68 DOTATATE PET/CT in the Detection of Metastasis Rate of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
by: Halil Komek, et al.
Published: (2019-06-01)

Radiomics-Based Texture Analysis of 68Ga-DOTATATE Positron Emission Tomography and Computed Tomography Images as a Prognostic Biomarker in Adults With Neuroendocrine Cancers Treated With 177Lu-DOTATATE
by: Charlotte Atkinson, et al.
Published: (2021-08-01)

Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma
by: Emily B. Ambinder, MD, et al.
Published: (2020-08-01)

68Ga-DOTATATE positron emission tomography/computed tomography to detect the recurrence of phosphaturic mesenhcymal tumor-induced osteomalacia
by: Manav I Bhalla, et al.
Published: (2020-01-01)

Diagnostic efficiency of 68Ga-DOTATATE PET/CT as compared to 99mTc-Octreotide SPECT/CT and conventional morphologic modalities in neuroendocrine tumors
by: Babak Fallahi, et al.
Published: (2019-06-01)

Two Birds with One Stone: Skull Base Meningioma and Jugulotympanic Paragangliomas with Somatostatin Receptor Positron Emission Tomography
by: Giorgio Treglia, et al.
Published: (2021-09-01)

Initial clinical evaluation of indigenous90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability,90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects
by: Rahul V Parghane, et al.
Published: (2021-01-01)

Metastatic clear cell renal cell carcinoma demonstrating intense uptake on 68Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature
by: David P Nadebaum, et al.
Published: (2018-01-01)

68Ga-DOTATATE-positron emission tomography imaging in spinal meningioma
by: Philipp Jorg Slotty, et al.
Published: (2014-01-01)

Changes in biodistribution on 68Ga-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression
by: Martin H. Cherk, et al.
Published: (2018-01-01)

Gastrointestinal neuroendocrine tumor with discordant metastatic disease on 111In-pentetreotide SPECT/CT, 18F-DOPA PET/CT and 68Ga-HA-DOTATATE PET/CT
by: Abele, J., et al.
Published: (2022)

Paget’s Disease Mimicking Bone Metastasis in a Patient with Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT
by: Naciye Sinem Gezer, et al.
Published: (2016-07-01)

Gallium‐68 DOTATATE Production with Automated PET Radiopharmaceutical Synthesis System: A Three Year Experience
by: Alireza Aslani, et al.
Published: (2014-10-01)

Elastofibroma Dorsi: Positron Emission Tomography/Computed Tomography Perspective
by: Tamer Aksoy
Published: (2019-09-01)

<sup>68</sup>Ga-DOTATOC PET/CT Follow Up after Single or Hypofractionated Gamma Knife ICON Radiosurgery for Meningioma Patients
by: Fabio Barone, et al.
Published: (2021-03-01)

68Ga-DOTATOC-PET/MRI—A Secure One-Stop Shop Imaging Tool for Robotic Radiosurgery Treatment Planning in Patients with Optic Nerve Sheath Meningioma
by: Josefine Graef, et al.
Published: (2021-07-01)

A physiologically based pharmacokinetic (PBPK) model to describe organ distribution of 68Ga-DOTATATE in patients without neuroendocrine tumors
by: H. Siebinga, et al.
Published: (2021-08-01)

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma
by: Abhishek Jha, et al.
Published: (2019-02-01)

Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World
by: Mayank Patel, et al.
Published: (2021-03-01)

Influence of 68Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy
by: Falk Stade, et al.
Published: (2018-04-01)

Initial Experience with <sup>64</sup>Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET
by: Mathias Loft, et al.
Published: (2021-02-01)

A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting
by: Rosalba Mansi, et al.
Published: (2020-08-01)

Diagnostic Utility of PET CT in Thymic Tumours with Emphasis on 68Ga-DOTATATE PET CT in Thymic Neuroendocrine Tumour - Experience at a Tertiary Level Hospital in India
by: Julie Hephzibah, et al.
Published: (2014-09-01)

Instant kit preparation of 68Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [68Ga]Ga-DATA-TOC
by: Jean-Philippe Sinnes, et al.
Published: (2019-05-01)

Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in 68Ga-DOTATATE PET/CT studies?
by: Alexandre Chicheportiche, et al.
Published: (2021-02-01)

Magnetic resonance imaging, computed tomography, and <sup>68</sup>Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy - a case series
by: Graf Reinhold, et al.
Published: (2012-01-01)

Incidental Diagnosis of Multiple Paragangliomas by Ga-68 DOTANOC Positron Emission Tomography-Computed Tomography
by: Vivek Saini, et al.
Published: (2021-07-01)

The eye of the beholder: orbital metastases from midgut neuroendocrine tumors, a two institution experience
by: Satya Das, et al.
Published: (2018-12-01)

68Ga-PSMA PET/CT in prostate cancer patients – patterns of disease, benign findings and pitfalls
by: Zohar Keidar, et al.
Published: (2018-11-01)

Cannot write session to /tmp/vufind_sessions/sess_9kqmjd398gqc4b4n231t150uu9